4ª Prorroga Suministro de NATALIZUMAB jeringa (TYSABRI) y DIROXIMEL FUMARATO cápsula (VUMERITY) de distribución exclusiva con destino al Servicio de Farmacia del Hospital Clínico San Carlos de Madrid

Deadline:N/A

We were not able to find a link to the source, please find contact details in the documents.

Tender information

Madrid

Type

Contract award

Procedure

Negotiated without a call for competition

Ref. number

PNSP 2023-1-067

Estimated value

€2,434,682.33

Contract type

Dynamic purchasing system

Duration

6 months

4ª Prorroga Suministro de NATALIZUMAB jeringa (TYSABRI) y DIROXIMEL FUMARATO cápsula (VUMERITY) de distribución exclusiva con destino al Servicio de Farmacia del Hospital Clínico San Carlos de Madrid

Buyer

Hospital Clinico San Carlos

Contract award

BIOGEN SPAIN S.L.

Awarded

Documents

Document name	Upload date	File size
First document.pdf	1 Jan 1970, 00:00	1 Bytes
Second document.pdf	1 Jan 1970, 00:00	1 Bytes

Contract award

BIOGEN SPAIN S.L.

Awarded

Information on this page originates from the following sources: TED

Buyer

Hospital Clinico San Carlos

Contract awarded

Important dates

5 Aug - Publication date

Unlock Full Access with Mercell Bidding Business Plus

Start your free trial to explore exclusive features that help you win more tenders, faster:

AI-Powered Tender Insights

Buyer Contact Info

Key Tender Timelines

Already have an account?

We were not able to find a link to the source, please find contact details in the documents.

4ª Prorroga Suministro de NATALIZUMAB jeringa (TYSABRI) y DIROXIMEL FUMARATO cápsula (VUMERITY) de distribución exclusiva con destino al Servicio de Farmacia del Hospital Clínico San Carlos de Madrid

Documents

Your privacy is important to us